TechnologyPatent OppositionCompetitive Analysis

Explore the competitive field of Medicinal Granules And Particles where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in Medicinal Granules And Particles technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Medicinal Granules And Particles

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Medicinal Granules And Particles industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Medicinal Granules And Particles industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Aug 21, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Medicinal Granules And Particles industry

Nucleic Acid VaccinesMODERNATXJul 9, 2025BIONTECH
Nucleic Acid VaccinesMODERNATXJul 9, 2025BIONTECH
Nucleic Acid VaccinesMODERNATXJul 4, 2025PFIZER
Nucleic Acid VaccinesMODERNATXJul 4, 2025PFIZER
Process Of Spray Drying Of Glp-1 PeptideNOVO NORDISKJun 11, 2025GENERICS UK
Modified Release Orally Administered Amino Acid FormulationsAPR APPLIED PHARMA RESEARCHJun 10, 2025MAIWALD
Compositions Of 1-(4-Bromo-5-(1-Ethyl-7-(Methylamino)-2-Oxo-1,2-Dihydro-1,6-Naphthyridin-3-Yl)-2-Fluorophenyl)-3-PhenylureaDECIPHERA PHARMACEUTICALSMay 28, 2025ALFRED E TIEFENBACHER
Nucleic Acid VaccinesMODERNATXMar 3, 2025SANOFI
Nucleic Acid VaccinesMODERNATXMar 3, 2025SANOFI
Apixaban FormulationsBRISTOL MYERS SQUIBBDec 19, 2024STADA ARZNEIMITTEL

To stay ahead in the competitive Medicinal Granules And Particles industry, companies are constantly innovating. Here are the top patents facing oppositions in the Medicinal Granules And Particles industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM18
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneMUNDIPHARMA11
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneMUNDIPHARMA11
Aug 18, 2021Formulations Of EnzalutamideMEDIVATION PROSTATE THERAPEUTICS11
Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNATX10
Jul 3, 2019Pharmaceutical Compositions Comprising An S1P ModulatorNOVARTIS7
Apr 14, 2021Tablet Formulation Comprising A Peptide And A Delivery AgentNOVO NORDISK7
Mar 11, 2020Pharmaceutical Formulations Containing Dapagliflozin Propylene Glycol HydrateBRISTOL MYERS SQUIBB6
May 10, 2023Pharmaceutical Formulations Containing Dapagliflozin Propylene Glycol HydrateBRISTOL MYERS SQUIBB5
Dec 22, 2021Nucleic Acid VaccinesMODERNATX5